Xponance Inc. Purchases New Stake in M.D.C. Holdings, Inc. (NYSE:MDC)

Xponance Inc. purchased a new stake in M.D.C. Holdings, Inc. (NYSE:MDC) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,623 shares of the construction company’s stock, valued at approximately $200,000.

Several other institutional investors have also recently added to or reduced their stakes in MDC. Sound Income Strategies LLC acquired a new stake in M.D.C. in the fourth quarter valued at $25,000. McGlone Suttner Wealth Management Inc. acquired a new stake in M.D.C. in the fourth quarter valued at $25,000. Clear Street Markets LLC acquired a new stake in M.D.C. in the third quarter valued at $29,000. Kingswood Wealth Advisors LLC acquired a new stake in M.D.C. in the fourth quarter valued at $40,000. Finally, Blue Trust Inc. raised its holdings in M.D.C. by 64.1% in the fourth quarter. Blue Trust Inc. now owns 1,050 shares of the construction company’s stock valued at $58,000 after acquiring an additional 410 shares in the last quarter. 88.08% of the stock is owned by institutional investors and hedge funds.

M.D.C. Stock Up 0.0 %

M.D.C. stock opened at $62.98 on Monday. The company has a 50-day simple moving average of $62.79 and a 200-day simple moving average of $54.83. The firm has a market capitalization of $4.73 billion, a P/E ratio of 11.93 and a beta of 1.54. The company has a debt-to-equity ratio of 0.50, a quick ratio of 3.92 and a current ratio of 9.76. M.D.C. Holdings, Inc. has a one year low of $36.47 and a one year high of $63.00.

M.D.C. (NYSE:MDC) last announced its earnings results on Tuesday, January 30th. The construction company reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.50 by $0.06. M.D.C. had a net margin of 8.64% and a return on equity of 12.32%. The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter in the prior year, the firm posted $1.08 EPS. M.D.C.’s revenue was down 11.9% compared to the same quarter last year. As a group, equities analysts expect that M.D.C. Holdings, Inc. will post 5.7 earnings per share for the current year.

Insider Buying and Selling at M.D.C.

In other M.D.C. news, Director David E. Blackford sold 6,200 shares of the company’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $62.69, for a total transaction of $388,678.00. Following the completion of the sale, the director now directly owns 13,534 shares of the company’s stock, valued at $848,446.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 23.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have weighed in on MDC shares. Raymond James reissued a “market perform” rating on shares of M.D.C. in a report on Wednesday, February 7th. StockNews.com started coverage on shares of M.D.C. in a report on Saturday. They set a “hold” rating on the stock. Finally, Evercore ISI cut shares of M.D.C. from an “outperform” rating to an “in-line” rating and increased their target price for the stock from $57.00 to $63.00 in a report on Wednesday, January 31st. One research analyst has rated the stock with a sell rating and five have given a hold rating to the company. Based on data from MarketBeat, M.D.C. presently has an average rating of “Hold” and a consensus price target of $52.13.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.